Monthly Archives: February 2020

IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces it is Investigating Claims Against Telenav, Inc. and Encourages Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / February 27, 2020 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Telenav, Inc. ("Telenav" or "the Company") (NASDAQ:TNAV) for violations of the securities laws.

The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Telenav admitted on February 11, 2020, that it would be unable to file its quarterly report for the period ended December 31, 2019, in a timely manner. The Company filed a Form 12b-25 filed with the SEC, stating that it had "updated its reporting of revenue related to its agreements with Grab Holdings, Inc." which resulted in revenue corrections for the quarter ending September 30, 2019, among other adjustments. Telenav also admitted, "a material weakness in its internal control over financial reporting. If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at brian@schallfirm.com.

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:
The Schall Law Firm
Brian Schall, Esq.
310-301-3335
Cell: 424-303-1964
info@schallfirm.com
www.schallfirm.com

SOURCE: The Schall Law Firm

ReleaseID: 578290

(CCI) Investor Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Crown Castle International Corp.

NEW YORK, NY / ACCESSWIRE / February 27, 2020 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Crown Castle International Corp. ("Crown Castle" or the Company") (NYSE:CCI). Investors who purchased Crown Castle securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: www.bgandg.com/cci.

The investigation concerns whether Crown Castle and certain of its officers and/or directors have violated federal securities laws.

On February 26, 2020, Crown Castle disclosed that its historical accounting practice with respect to recognizing servicing revenues from its tower installation services "was not acceptable under GAAP." The Company advised investors that it would restate its financial statements for the years ended December 31, 2018 and 2017 and for the first three quarters in the year ended December 31, 2019. On this news, Crown Castle's stock price fell sharply during intraday trading on February 27, 2020.

If you are aware of any facts relating to this investigation, or purchased Crown Castle shares, you can assist this investigation by visiting the firm's site: www.bgandg.com/cci. You can also contact Peretz Bronstein or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC

ReleaseID: 578289

IMPORTANT INVESTOR NOTICE: The Schall Law Firm Announces it is Investigating Claims Against HP Inc. and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / February 27, 2020 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of HP Inc. ("HP" or "the Company") (NYSE:HPQ) for violations of the securities laws.

The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. HP lacked telemetry data from commercial printers and had to rely on stagnant and inaccurate market share data to develop assumptions for its four-box model. The lack of solid data was a serious weakness for the commercial printing business because the Company knew from its personal printing division how important accurate data is. Based on this critical weakness, the Company exceeded demand in the supply chain by at least $100 million, grossly inflating its supplies revenue. Based on these facts, the Company's public statements were false and materially misleading throughout the class period. When the market learned the truth about HP, investors suffered damages.

If you are a shareholder who suffered a loss, click here to participate.

The class in this case has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm
Brian Schall, Esq.
310-301-3335
Cell: 424-303-1964
info@schallfirm.com
www.schallfirm.com

SOURCE: The Schall Law Firm

ReleaseID: 578288

Stem Cell Therapy for Coronavirus Infection

GOLDEN, CO / ACCESSWIRE / February 27, 2020 /Vitro Diagnostics, Inc. (OTCPK:VODG), dba Vitro Biopharma reports on a potential therapy of Coronavirus (COVID-19) infections by stem cell transplant. While this therapy is not a method to eradicate or cure Coronavirus, there is evidence to support the concept that infected patients may be more likely to combat and survive infection. First, stem cells resist viral attack by the expression of certain genes known as interferon gamma stimulated genes (ISGs). These are expressed in stem cells prior to their differentiation. (Wu, X, et al, Cell 172: 423, 2018). Hence, stem cells would be expected to survive even if transplanted into a patient with an active Coronavirus infection. Also, it is known that stem cells rejuvenate and regenerate cells in the body through various processes involving reduction of inflammation, secretion of substances that protect cells, transfer of mitochondria, reduction of cell death, anti-oxidative effects and improvement of immune system function. These effects are likely to increase survival in patients infected with Coronavirus. Also, there is direct evidence of stem cell protection against viral infection. Influenza virus A/H5N1 causes acute lung injury that was reduced by human mesenchymal stromal cells (MSCs) in mice and the treatment increased survival (Chan, et al, PNAS 113:3621, 2016).

Vitro Biopharma has operated a highly regulated, FDA-compliant commercial biologics manufacturing facility for several years and is cGMP compliant, ISO9001 Certified, ISO13485 Certified, CLIA Certified and FDA registered. All clinical manufacturing occurs in a certified sterile clean room with extensive and advanced testing to assure the absence of contamination. Furthermore, in numerous patients treated to date by IV infusion of our AlloRx Stem Cells™ there have been no significant adverse events while we have gained evidence of efficacy. We presently supply our AlloRx™ Stem Cells to DVC Stem in the Cayman Islands for treatment of inflammatory conditions. We plan to begin recruitment of patients for a trial of stem cell therapy of musculoskeletal conditions in the Bahamas during spring 2020.

Dr. Jim Musick, CEO said, "We are pleased to be positioned to offer stem cell therapy for Coronavirus infection. While there are several factors related to the possible extent of this global infection, stem cell therapy represents a therapeutic option to fight the virus and increase survival while effective vaccines are being developed. Our existing off-shore partners offer stem cell transplant services and we are in contact with CDC officials regarding potential US-based stem cell transplants into infected individuals."

About Vitro Biopharma

Vitro Biopharma, for over 10 years, has supplied major biopharmaceutical firms, elite university laboratories and clinical trials worldwide with Mesenchymal Stem Cells, the MSC-Grow™ Brand of cell culture media, various stem cell derivatives and stem cell-derived differentiated cells. We also manufacture primary fibroblast cells and an expanding line of cancer-associated fibroblasts (CAFs) from various tumors including lung, breast, melanoma, pancreatic, glioblastoma and colorectal tissues. Our CAFs are purchased by major pharmaceutical and biopharmaceutical firms to advance immunotherapy of cancer.

Out of our years of research, we developed our patent-pending and proprietary line of umbilical cord-derived stem cells AlloRx™ Stem Cells now being used in offshore regenerative medicine clinical trials. Our stem cells are used in regenerative medicine clinical trials with our partner in the Cayman Islands www.DVCStem.com. We have a recently approved clinical trial using our AlloRx™ Stem Cells to treat musculoskeletal conditions at The Medical Pavilion of the Bahamas www.tmp-bahamas.com in Nassau. We are supporting clinical studies of stem cell therapies using our AlloRx™ Stem Cells for osteoarthritis, neurodegenerative diseases including Parkinson's disease, Multiple Sclerosis and Alzheimer's disease while pursuing select US markets for stem cell therapies.

We support our regenerative therapies with NutraVivo™/STEMulize™, a nutraceutical Stem Cell Activator that has been shown to induce proliferation, migration and epigenetic modification of human adult stem cells. NutraVivo™ improves overall cellular wellness and significantly increases expression of anti-aging genes.

Forward-Looking Statements

Statements herein regarding financial performance have not yet been reported to the SEC nor reviewed by the Company's auditors. Certain statements contained herein and subsequent statements made by and on behalf of the Company, whether oral or written may contain "forward-looking statements". Such forward-looking statements are identified by words such as "intends," "anticipates," "believes," "expects" and "hopes" and include, without limitation, statements regarding the Company's plan of business operations, product research and development activities, potential contractual arrangements, receipt of working capital, anticipated revenues and related expenditures. Factors that could cause actual results to differ materially include, among others, acceptability of the Company's products in the market place, general economic conditions, receipt of additional working capital, the overall state of the biotechnology industry and other factors set forth in the Company's filings with the Securities and Exchange Commission. Most of these factors are outside the control of the Company. Investors are cautioned not to put undue reliance on forward-looking statements. Except as otherwise required by applicable securities statutes or regulations, the Company disclaims any intent or obligation to update publicly these forward-looking statements, whether as a result of new information, future events or otherwise.

CONTACT:

Dr. James Musick
Chief Executive Officer
Vitro Biopharma
(303) 999-2130 Ext. 1
E-mail: jim@vitrobiopharma.com

SOURCE: Vitro Diagnostics, Inc.

ReleaseID: 578276

INVESTOR ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Alpha and Omega Semiconductor Limited and Encourages Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / February 27, 2020 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Alpha and Omega Semiconductor Limited ("AOS" or "the Company") (NASDAQ:AOSL) for violations of the securities laws.

The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. AOS announced its financial results for the second fiscal quarter of 2020 on February 5, 2020. The Company admitted that the DOJ had "recently commenced an investigation into the Company's compliance with export control regulations relating to certain business transactions with Huawei and its affiliates (‘Huawei')" and that "in connection with this investigation, [the Department of Commerce] has requested the Company to suspend shipments of its products to Huawei . . . . Accordingly, we expect the financial performance in the March quarter will be negatively impacted by the Huawei shipment interruption and by additional professional fees incurred in connection with the investigation." Based on this news, shares of AOS fell by 12% on the next day.

If you are a shareholder who suffered a loss, click here to participate.

The class in this case has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm
Brian Schall, Esq.
310-301-3335
info@schallfirm.com
www.schallfirm.com

SOURCE: The Schall Law Firm

ReleaseID: 578281

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Tivity Health, Inc. of Class Action Lawsuit and Upcoming Deadline – TVTY

NEW YORK, NY / ACCESSWIRE / February 27, 2020 / Pomerantz LLP announces that a class action lawsuit has been filed against Tivity Health, Inc. ("Tivity" or the "Company") (NASDAQ:TVTY) and certain of its officers. The class action, filed in United States District Court, for the Middle District of Tennessee, and indexed under 20-cv-00165, is on behalf of a class consisting of all persons and entities other than Defendants who purchased or otherwise acquired Tivity securities between March 8, 2019, and February 19, 2020, both dates inclusive (the "Class Period"), seeking to recover damages caused by Defendants' violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the "Exchange Act") and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.

If you are a shareholder who purchased Tivity securities during the class period, you have until April 27, 2020, to ask the Court to appoint you as Lead Plaintiff for the class. A copy of the Complaint can be obtained at www.pomerantzlaw.com. To discuss this action, contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext. 9980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

[Click here for information about joining the class action]

Tivity provides fitness and health improvement programs in the United States. The Company was formerly known as Healthways, Inc. and changed its name to Tivity Health, Inc. in January 2017.

In December 2018, Tivity announced that it would acquire Nutrisystem, Inc. ("Nutrisystem"), a provider of weight management products and services (the "Nutrisystem Acquisition"). On March 8, 2019, Tivity announced the completion of the Nutrisystem Acquisition for approximately $1.3 billion in cash and stock.

The Complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements regarding the Company's business, operational and compliance policies. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (i) following the Nutrisystem Acquisition, Tivity's Nutrition segment faced significant operational challenges; (ii) the foregoing would foreseeably have a significant impact on Tivity's revenues; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times.

On February 19, 2020, Tivity issued a press release announcing the Company's financial results for the fourth quarter and year ended December 31, 2019. Tivity disclosed, inter alia, that its "Nutrition segment had a disappointing end to 2019," which included "a non-cash impairment charge of $(377.1) million," contributing to a net loss for the Company of $272.8 million in the fourth quarter. Concurrently, Tivity announced the resignation of the Company's Chief Executive Officer ("CEO") Donato Tramuto, effective immediately. Discussing the Company's financial results on an earnings call, the Company's interim CEO, Robert Greczyn, stated that "[a]dmittedly, the nutrition business has not worked out as well as planned since the completion of the [Nutrisystem Acquisition] in March 2019.

On this news, Tivity's stock price fell $10.43 per share, or 45.49%, to close at $12.50 per share on February 20, 2020.

The Pomerantz Firm, with offices in New York, Chicago, Los Angeles, and Paris, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com

SOURCE: Pomerantz LLP

ReleaseID: 578280

Sphinx obtient des résultats supportant l’extension de la zone cupro-aurifère Shea et son lien avec des anomalies géophysiques et géochimiques dans les roches métavolcaniques de la propriété Calumet-Nord dans la MRC de Pontiac au Québec

MONTRÉAL, QC / ACCESSWIRE / le 27 février 2020 / Ressources Sphinx ltée. (« Sphinx ») (TSX-V : SFX) annonce les résultats de rainures sur le décapage de la zone Shea (cf communiqué de presse du 16 octobre 2019) ainsi que ceux de levés pédogéochimique et de polarisation provoquée sur la propriété Calumet-Nord. La propriété Calumet-Nord est située sur l'île du Grand-Calumet dans la MRC du Pontiac dans le Sud-Ouest du Québec (Fig. 1).

Pour faire suite au communiqué de presse du 16 octobre dernier qui annonçait les résultats d'analyses d'échantillons choisis, Sphinx a procédé au rainurage systématique du décapage Shea. Le long de ces rainures, des échantillons ont été prélevés systématiquement sur des longueurs métriques (Fig. 2). Ceux-ci ont été analysés par Laboratoire Expert inc. de Rouyn-Noranda (tableau 1). Les résultats de ces rainures supportent que la zone cupro-aurifère fait de 8 à 10 mètres de largeur et se suit sur les 95 mètres de longueur du décapage. Cette minéralisation volcanogène épigénétique précoce est disséminée dans une ‘dalmatianite' à savoir un schiste à sillimanite, muscovite, feldspath potassique, grenat et biotite.

Afin de connaître l'envergure du système polymétallique aurifère volcanogène sur la propriété Calumet-Nord, d'octobre à décembre 2019, Sphinx a fait faire 75,9 kilomètres de levé de polarisation provoquée (Tshimbalanga, 2020). Ce levé géophysique a révélé de très nombreuses anomalies, en particulier sous le décapage Shea et dans son extension. Ces axes anomaux n'ont jamais été vérifiés par des forages. Il en va de même pour les anomalies géophysiques décelées près des zones polymétalliques du secteur des gîtes Lasalle et Cordiérite (Fig. 1). En 2019, Sphinx a également prélevé 6564 échantillons de sol sur la propriété Calumet-Nord. Afin de déceler le signal pédogéochimique de minéralisations polymétalliques dans ces sols un XRF portatif Niton fût utilisé. C'est ainsi qu'a été observé la coïncidence d'un signal pédogéochimique cupro-aurifère franc avec les axes des anomalies de polarisation provoquée du secteur du décapage Shea. Ce corridor prioritaire pour une campagne de forage a pu ainsi être retracé sur deux kilomètres de longueur en direction de l'ancienne mine New Calumet qui a produit de 1944 à 1968, 3,8 millions de tonnes de matériaux minéralisés titrant 5,8% de zinc, 1,6% de plomb, 0,3% de cuivre, 65 g/t d'argent et 0,4 g/t d'or. Des zones aurifères significatives (cf. Fig. 4 du communiqué du 17 octobre 2019) ont été laissées dans cette mine, car celle-ci a cessé son exploitation avant que l'or ne soit plus fixé à 35 $ US/once à partir de 1972.

À la suite de ces résultats très positifs, Sphinx envisage une campagne de forages sur les nombreuses cibles volcanogènes polymétalliques identifiées sur Calumet-Nord. Une proportion importante des cibles de forages envisagées se situent sur des terrains non-grevés par le zonage agricole et peuvent donc être d'ores et déjà forées. Par contre pour celles situées en zone agricole une autorisation de la Commission de Protection du Territoire Agricole du Québec (CPTAQ) doit être obtenue au préalable pour que des forages puissent être implantés.

Références :

Gauthier, M., 2020. Rapport des travaux effectués d'octobre 2018 à octobre 2019 sur la propriété Calumet-Nord de Ressources Tranchemontagne Inc.. Rapport soumis par Ressources Sphinx ltée au Ministère de l'Énergie et des Ressources naturelles du Québec, 241 pages.
Tshimbalanga, S.T., 2020. Levé de polarisation provoquée, projet Calumet-Nord, Ile du Grand-Calumet, MRC Pontiac. Rapport soumis à Ressources Sphinx ltée. par Geosig Inc., 24 pages.

Protocole analytique

Les analyses géochimiques pour l'or ont été effectuées par pyroanalyse sur une prise de 30 g et une finition par absorption atomique. Les résultats supérieurs à 1000ppb ont été ré-analysés par pyroanalyse sur une prise de 30 g et finition gravimétrique. Les analyses géochimiques de métaux de base ont été effectuées par absorption atomique après une dissolution totale par 3 acides sur une prise de 0.5 g. Les analyses ont été effectuées par Laboratoire Expert de Rouyn-Noranda, Québec.

Nomination au comité consultatif

Les membres du conseil d'administration sont heureux d'annoncer la nomination de Pierre-André Viens au comité consultatif. M. Viens est administrateur et vice-président finance de CMAC-Thyssen Global Holding inc. où il est responsable du financement et du développement des affaires. Antérieurement, M. Viens a travaillé chez Xstrata Nickel à la mine Koniambo Nickel SAS et Mines Raglan en tant que chef de projet – performance opérationnelle et ingénieur en développement d'affaires respectivement. De 2005 à 2007, M. Viens a été directeur à l'investissement chez Desjardins Capital de Risque. De 2003 à 2005 il a été analyste à l'investissement chez Innovatech Régions Ressources.

M. Viens détient un MBA, une maîtrise en économie minérale (département de génie minier), un baccalauréat en administration des affaires (option finance) ainsi qu'un baccalauréat en génie minier, tous obtenus à l'Université Laval. M. Viens est et membre de l'Ordre des ingénieurs du Québec et il détient la charte CFA.

Personne qualifiée

Ce communiqué de presse a été préparé par Michel Gauthier, (PhD, FSEG, Géo., administrateur de la Société) personne qualifiée en vertu du Règlement canadien 43-101 sur les normes de divulgation concernant les projets miniers. M. Gauthier est également administrateur de la Société.

Au sujet de Sphinx

Sphinx est une société d'exploration minière qui concentre ses activités dans le sud-ouest du Québec à la recherche de gisements de métaux précieux (or, argent, palladium et platine,) et de métaux usuels (cuivre, zinc et plomb). La Société est tout particulièrement active dans la MRC du Pontiac où demeure son président. Elle bénéficie d'un important actionnariat local qui contribue à l'acceptabilité sociale.

Pour plus de renseignements, veuillez consulter le site web de Sphinx ou communiquer avec la personne suivante :

Jeremie Ryan
Président et chef de la direction
819 664 2632

info@sphinxresources.ca
www.sphinxresources.ca

TABLEAU 1 :

No
Echantillon

AuPPB

AgPPM

CuPPM

NiPPM

PbPPM

ZnPPM

UtmEst
(N83Z18)

UtmNord
(N83Z18)

F30551

-5

-0,2

468,5

100

368460,57

5064847,38

F30552

-5

-0,2

240

110

368460,58

5064846,58

F30553

-5

-0,2

436

368460,53

5064845,91

F30554

0,3

615

368460,54

5064845,18

F30555

-5

0,3

779

368460,49

5064844,17

F30556

2,6

6300

116

368460,4

5064843,17

F30557

1,1

2005

126

368460,36

5064842,23

F30558

-5

0,5

1446

368460,28

5064841,33

F30559

0,8

1496

368460,26

5064840,34

F30560

-5

0,6

1087

368460,12

5064839,34

F30561

-5

0,4

1083

368460,04

5064838,37

F30562

-5

-0,2

122

220

368459,91

5064837,51

F30563

-5

0,4

807

91,5

368463,31

5064845,69

F30564

1,7

4320

147

368463,25

5064844,81

F30565

0,8

2690

368463,29

5064843,84

F30566

0,7

1447

368463,31

5064842,83

F30567

1923

368463,35

5064841,83

F30568

2,5

7340

368463,51

5064840,94

F30569

0,4

1032

368463,71

5064839,98

F30570

1880

368463,69

5064839,07

F30571

-5

0,3

453

368467,68

5064848,42

F30572

0,5

1312

368467,64

5064847,5

F30573

0,3

320

103

368467,45

5064846,58

F30574

0,9

1409

162

368467,27

5064845,6

F30575

104,5

1,85

7155

123

368467,06

5064844,78

F30576

0,6

1447

309

368466,53

5064844,04

TABLEAU 1 (SUITE) :

No
Echantillon

AuPPB

AgPPM

CuPPM

NiPPM

PbPPM

ZnPPM

UtmEst
(N83Z18)

UtmNord
(N83Z18)

F30577

0,9

1691

162

368466,42

5064843

F30578

1,1

1901

112

368466,4

5064842,1

F30579

2670

368466,35

5064841,1

F30580

1,7

2620

368466,32

5064840

F30581

2740

368466,22

5064839,06

F30582

0,9

2660

368466,13

5064838,12

F30583

0,5

1155

368469,93

5064848

F30584

-5

0,4

829

368469,86

5064846,98

F30585

494

7,6

22900

211

368469,78

5064846,11

F30586

1,2

2240

368469,61

5064845,17

F30587

0,65

1479

14,5

128,5

368469,44

5064844,19

F30588

195

3,2

7295

9,5

368469,28

5064843,27

F30589

1,9

4950

368469,18

5064842,31

F30590

-5

0,2

209

107

368469,07

5064841,31

F30591

-5

-0,2

151

168

368468,91

5064840,28

F30592

-5

-0,2

114

368468,85

5064839,42

F30593

-5

0,3

119

118

368468,78

5064838,74

F30594

0,7

1930

368473,99

5064850,23

F30595

-5

-0,2

301

368474,02

5064849,33

F30596

0,4

1070

368473,98

5064848,45

F30597

3110

213

368473,83

5064847,61

F30598

3130

303

368473,66

5064846,76

F30599

-5

0,4

760

234

368473,48

5064845,99

F30600

0,8

1551,5

8,5

12,5

123,5

368473,35

5064845,04

F30601

1,7

7270

368473,31

5064844,16

F30602

216

2,4

5330

368473,22

5064843,24

TABLEAU 1 (SUITE) :

No
Echantillon

AuPPB

AgPPM

CuPPM

NiPPM

PbPPM

ZnPPM

UtmEst
(N83Z18)

UtmNord
(N83Z18)

F30603

3,5

8500

368473,12

5064842,41

F30604

1,9

6180

309

368479,86

5064847,88

F30605

0,3

588

355

368479,74

5064846,96

F30606

0,5

1032

368479,56

5064845,98

F30607

0,6

1103

368479,41

5064845,02

F30608

2,1

5090

368479,3

5064843,95

F30609

1911

368479,15

5064842,95

F30610

-5

0,4

822

368479,01

5064842,01

F30611

-5

-0,2

237

100

368478,84

5064841,01

F30612

0,35

248,5

110,5

368478,73

5064840,02

F30613

-5

0,2

111

112

368478,6

5064839,08

F30614

0,2

131

157

368478,61

5064837,97

F30615

0,7

1657

143

368482,49

5064848,5

F30616

1,2

1982

368482,39

5064847,73

F30617

-5

0,3

451

368482,32

5064846,74

F30618

-5

0,3

891

368482,28

5064845,76

F30619

1,5

4970

368482,1

5064844,65

F30620

1,7

3990

368488,41

5064848,71

F30621

0,2

622

368488,45

5064847,83

F30622

-0,2

170

368488,46

5064846,88

F30623

0,2

325

368488,41

5064845,79

F30624

7,5

0,3

917,5

10,5

62,5

368488,39

5064844,85

F30625

1,95

6120

58,5

368481,92

5064843,52

F30626

1924

368481,72

5064842,56

F30627

-5

0,6

1566

122

368488,39

5064843,92

F30628

1,8

4430

368488,47

5064843,25

TABLEAU 1 (SUITE) :

No
Echantillon

AuPPB

AgPPM

CuPPM

NiPPM

PbPPM

ZnPPM

UtmEst
(N83Z18)

UtmNord
(N83Z18)

F30629

1,7

5760

368490,87

5064850,09

F30630

1,5

3560

113

368491,04

5064849,05

F30631

-5

0,5

1131

154

368491,26

5064848,1

F30632

-5

-0,2

211

368491,37

5064847,22

F30633

-5

-0,2

194

368491,61

5064846,25

F30634

-5

-0,2

624

368491,83

5064845,25

F30635

-5

0,4

968

368492,07

5064844,39

F30636

1,2

3160

368492,25

5064843,5

F30637

46,5

1,3

2690

9,5

368492,4

5064841,48

F30638

0,8

1924

368492,34

5064842,51

F30639

-5

0,3

749

368481,3

5064841,5

F30640

-5

-0,2

158

124

368481,24

5064840,56

F30641

-5

-0,2

108

192

368481,24

5064839,66

F30642

-5

-0,2

480

368494,07

5064852

F30643

-5

-0,2

414

368494,24

5064851,03

F30644

0,6

1467

368494,4

5064850,08

F30645

1,5

3840

368494,48

5064849,11

F30646

1,3

2790

368494,7

5064848,18

F30647

-5

-0,2

221

368494,92

5064847,21

F30648

-5

0,2

460

368495,06

5064846,37

F30649

-5

-0,2

194

10,5

88,5

368495,16

5064845,31

F30650

-5

-0,2

307

368495,27

5064844,61

F30651

1,3

2530

368495,67

5064842,97

F30652

0,6

1250

234

368496,08

5064841,95

F30653

2,3

8690

154

368496,36

5064841,08

F30654

-0,2

584

368498,05

5064852,31

TABLEAU 1 (SUITE) :

No
Echantillon

AuPPB

AgPPM

CuPPM

NiPPM

PbPPM

ZnPPM

UtmEst
(N83Z18)

UtmNord
(N83Z18)

F30655

0,2

1024

368498,06

5064851,41

F30656

0,3

1619

368498,08

5064850,38

F30657

-5

0,3

755

368498,15

5064849,37

F30658

2,1

5160

368498,22

5064848,31

F30659

-5

0,4

557

198

368498,23

5064847,35

F30660

0,3

653

368498,34

5064846,33

F30661

-5

0,35

901

10,5

67,5

368498,77

5064845,35

F30665

-5

0,3

1312

104

368508,5

5064843,84

F30666

1,8

4100

368508,2

5064842,6

F30667

1,2

2840

184

368511,42

5064843,93

F30668

1,5

3150

368511,33

5064843

F30669

-5

0,4

726

368511,16

5064841,99

F30670

-5

-0,2

527

322

368514,56

5064845,41

F30671

644

5730

160

368514,5

5064844,5

F30672

1,4

2880

368514,33

5064843,46

F30673

-0,2

709

368519,1

5064848,01

F30674

40,5

1,35

5010

10,5

96,5

368518,78

5064847,07

F30675

1,3

3230

368518,39

5064845,99

F30676

0,5

1095

368518,17

5064844,99

F30677

0,8

1546

213

368517,94

5064844,02

F30678

108

2,6

5900

278

368517,76

5064843,16

F30679

190

2,8

9070

368517,57

5064842,13

F30680

1,8

6290

368517,2

5064841,25

F30681

-5

0,2

890

368517,05

5064840,3

F30682

1,8

6160

368516,99

5064839,29

F30683

-5

-0,2

597

368516,9

5064838,04

TABLEAU 1 (SUITE) :

No
Echantillon

AuPPB

AgPPM

CuPPM

NiPPM

PbPPM

ZnPPM

UtmEst
(N83Z18)

UtmNord
(N83Z18)

F30684

1,2

4210

127

368522,3

5064848,95

F30685

0,6

1079

368522,38

5064848,12

F30686

-5

0,7

1794

15,5

93,5

368522,46

5064847,12

F30687

-5

0,8

1492

427

368522,48

5064846,14

F30688

-5

0,4

763

572

368522,45

5064845,34

F30689

-5

0,4

1397

368522,46

5064844,74

F30690

162

2,3

7010

368522,35

5064844,04

F30691

1,6

3700

368522,24

5064843,18

F30692

-5

0,6

1257

116

368522,21

5064842,18

F30693

-5

0,2

814

368522,26

5064841,43

F30694

-5

-0,2

197

368522,17

5064840,74

F30695

-5

-0,2

713

134

368522,08

5064839,78

F30696

0,6

1450

122

368525,67

5064847,03

F30697

0,4

1199

126

368525,61

5064846,04

F30698

0,5

1494

108,5

368525,59

5064845,06

F30699

2,15

6425

15,5

299

368525,51

5064844,09

F30700

178

2,6

5840

148

368525,36

5064843,12

F30701

2,5

3610

368525,3

5064842,16

F30702

0,9

1789

200

368525,36

5064841,1

F30703

-5

0,8

1598

116

368525,47

5064840,09

F30704

2,3

6400

130

368528,15

5064848,41

F30705

2,2

4170

113

368527,88

5064847,49

F30706

0,3

448

368527,66

5064846,55

F30707

-5

0,2

268

368527,56

5064845,51

F30708

-5

0,4

548

368527,52

5064844,58

F30709

1,2

4160

368527,49

5064843,67

TABLEAU 1 (SUITE) :

No
Echantillon

AuPPB

AgPPM

CuPPM

NiPPM

PbPPM

ZnPPM

UtmEst
(N83Z18)

UtmNord
(N83Z18)

F30710

1860

368527,32

5064842,68

F30711

0,35

488

2,5

368527,4

5064841,72

F30712

0,5

1020

149

368527,38

5064840,79

F30713

-5

0,4

718

139

368527,41

5064840,1

F30714

-5

0,3

856

108

368531,51

5064848,09

F30715

2,6

5880

747

368531,48

5064847,12

F30716

-5

0,7

1085

204

368531,41

5064846,03

F30717

-5

0,5

1164

101

368531,34

5064845,14

F30718

0,8

1751

148

368531,29

5064844,11

F30719

-5

0,6

774

368531,15

5064843,21

F30720

0,3

487

368531

5064842,15

F30721

1,4

4330

113

368533,69

5064847,82

F30722

1,5

4410

130

368533,7

5064846,86

F30723

0,4

479,5

-2

11,5

368533,8

5064846

F30724

1,3

2670

368533,62

5064845,12

F30726

1,1

1503

368533,52

5064844,07

F30727

148

3,3

12600

160

368533,43

5064843,13

F30728

118

1,8

8050

119

368533,09

5064841,98

F30736

17,5

0,65

1629

12,5

368496,59

5064840,08

F30737

1,9

5630

368496,68

5064839,08

F30738

0,7

1617

368496,73

5064838,09

F30739

0,6

1266

368496,65

5064837,31

F30740

0,3

290

368496,6

5064836,61

F30741

-5

0,2

383

368496,55

5064835,84

F30742

0,3

1358

368496,54

5064835,26

F30743

-0,2

293

368496,32

5064834,49

TABLEAU 1 (SUITE) :

No
Echantillon

AuPPB

AgPPM

CuPPM

NiPPM

PbPPM

ZnPPM

UtmEst
(N83Z18)

UtmNord
(N83Z18)

F30744

-5

0,4

925

368506,65

5064843,2

F30745

-5

0,6

1304

368506,56

5064842,04

F30746

1,9

5420

368506,68

5064840,98

F30747

0,4

1202

368506,76

5064839,86

F30748

-0,2

826,5

51,5

368506,92

5064838,6

F30749

0,5

1105

368507,1

5064837,28

F30755

0,7

1651

368508,38

5064841,39

F30756

-5

0,3

1055

104

368508,61

5064840,2

F30757

-0,2

687

368508,72

5064839,14

F30758

-5

-0,2

582

368508,7

5064838,24

F30759

0,6

1507

368511,27

5064840,94

F30760

-5

-0,2

676

368511,09

5064839,97

F30761

-5

-0,2

501

368511,01

5064839,03

F30762

-5

-0,2

430

12,5

66,5

368510,91

5064837,95

F30763

1,9

6270

368514,09

5064842,62

F30764

-5

-0,2

985

368513,99

5064841,64

F30765

-5

-0,2

525

368513,88

5064840,83

F30766

-5

-0,2

370

368513,7

5064839,92

F30767

0,7

3020

368513,59

5064838,99

F30768

-5

-0,2

280

368513,62

5064837,99

F30770

-5

-0,2

262

368513,52

5064836,98

LA SOURCE : Ressources Sphinx ltée

ReleaseID: 578269

Sphinx’s Results Support the Extension of the Shea Copper-Gold Zone and its Correlation with Geophysical and Geochemical Anomalies in Metavolcanic Rocks on the Calumet-Nord Property, MRC Pontiac, Quebec

MONTREAL, QC / ACCESSWIRE / February 27, 2020 / Sphinx Resources Ltd ("Sphinx") (TSXV:SFX) is pleased to announce channel sampling results from the stripped outcrop on the Shea zone (see press release dated October 16, 2019) and the results of soil geochemistry and induced polarization surveys conducted on the Calumet-Nord property. The Calumet-Nord property is located on Ile-du-Grand-Calumet, in the Pontiac regional county municipality, southwestern Québec (Fig. 1).

Following the press release dated October 16, 2019, Sphinx carried out systematic channel sampling on the Shea stripped outcrop. Samples were collected at systematic one-metre intervals along each channel (Fig. 2). Collected samples were analyzed by Laboratoire Expert Inc. from Rouyn-Noranda (Table 1). Channel sampling results support that the copper-gold zone is 8 to 10 metres wide and can be traced across the entire 95-metre length of the exposed outcrop. This early epigenetic volcanogenic mineralization is disseminated in a "dalmatianite", i.e. a sillimanite-muscovite-potassic feldspar-garnet-biotite schist.

To establish the extent of the polymetallic gold-bearing volcanogenic system on the Calumet-Nord property, Sphinx had 75.9 kilometres of induced polarization surveys done from October to December 2019 (Tshimbalanga, 2020). This geophysical survey revealed a large number of anomalies, particularly under the Shea stripping and along its extensions. These anomalous axes have never been drill-tested; the same can be said of geophysical anomalies detected near polymetallic mineralization in the vicinity of the Lasalle and Cordierite deposits (Fig. 1). In 2019, Sphinx also collected 6,564 soil samples on the Calumet-Nord property. A handheld Niton XRF analyzer was used to detect the geochemical signature of polymetallic mineralization in soils. A

sharply defined copper-gold signature was observed in soils and coincides with induced polarization anomalies in the vicinity of the Shea stripping. This high-priority corridor for an upcoming drilling campaign was traced over a distance of two kilometres toward the former New Calumet mine which produced, from 1944 to 1968, 3.8 million tonnes of mineralized material grading 5.8% zinc, 1.6% lead, 0.3% copper, 65 g/t silver and 0.4 g/t gold. Significant gold-bearing zones (see Fig. 4 in the press release dated October 17, 2019) were left behind in the mine, as the latter ceased operations while the price of gold was still fixed at US$35/ounce.

Following these very positive results, Sphinx is considering a drilling campaign to test the numerous polymetallic volcanogenic targets identified on Calumet-Nord. A significant proportion of the drilling targets are located on lands not subject to agricultural zoning and are thus ready to be drill-tested. For targets located on agricultural lands, prior authorization from the Commission de Protection du Territoire Agricole du Québec (CPTAQ) must be obtained before a drilling campaign can be undertaken.

References:

Gauthier, M., 2020. Rapport des travaux effectués d'octobre 2018 à octobre 2019 sur la propriété Calumet-Nord de Ressources Tranchemontagne Inc.. Report submitted by Sphinx Resources Ltd to the Ministère de l'Énergie et des Ressources naturelles du Québec, 241 pages.
Tshimbalanga, S.T., 2020. Levé de polarisation provoquée, projet Calumet-Nord, Ile du Grand-Calumet, MRC Pontiac. Report submitted to Sphinx Resources Ltd by Geosig Inc., 24 pages.

Analytical Protocol

The gold geochemical analysis were performed by pyroanalysis on 30g weighted sample and an atomic absorption finish. The base metal geochemical analysis were performed by atomic absorption after total dissolution in 3 acids, on 0.5g weighted sample. The samples were analysed by Lab Expert Inc. laboratory from Rouyn-Noranda.

Appointment to the Advisory Committee

The members of the Board of Directors are pleased to announce the appointment of Pierre-André Viens to the Advisory Committee. Mr. Viens is Director and Vice-President, Finance of CMAC-Thyssen Global Holding Inc., where he is in charge of financing and corporate development. Previously, Mr. Viens worked for Xstrata Nickel at the Koniambo nickel mine and at the Raglan mine as Project Manager, Operational Performance and Corporate Development Engineer respectively. From 2005 to 2007, Mr. Viens was Investment Manager for Desjardins Capital de Risque. From 2003 to 2005, he served as an Investment Analyst for Innovatech Régions Ressources.

Mr. Viens holds an MBA, a master's degree in mineral economics (mining engineering department), a bachelor's degree in business administration (Finance) and a bachelor's degree in mining engineering, all from Université Laval. Mr. Viens is a member of the Ordre des ingénieurs du Québec and is holds the CFA designation.

Qualified Person

This press release was prepared by Michel Gauthier, Ph.D., FSEG, P.Geo., Qualified Person of the Corporation under National Instrument 43-101 – Standards of Disclosure for Mineral Projects. Mr. Gauthier is also a director of the Corporation.

About Sphinx

Sphinx is a mineral exploration company that focuses its activities in southwestern Quebec in search of deposits of precious metals (gold, silver, palladium and platinum) and base metals (copper, zinc and lead). Sphinx is particularly active in the MRC Pontiac where its President resides. It has a strong local shareholding that contributes towards social acceptability.

For further information, please consult Sphinx's website or contact:

Jeremie Ryan
President and Chief Executive Officer
819 664 2632

info@sphinxresources.ca
www.sphinxresources.ca

TABLE 1:

Sample #

Au
PPB

Ag
PPM

Cu
PPM

Ni
PPM

Pb
PPM

Zn
PPM

UTM East
(N83Z18)

UTM North
(N83Z18)

F30551

-5

-0.2

468.5

100

368460.57

5064847.38

F30552

-5

-0.2

240

110

368460.58

5064846.58

F30553

-5

-0.2

436

368460.53

5064845.91

F30554

0.3

615

368460.54

5064845.18

F30555

-5

0.3

779

368460.49

5064844.17

F30556

2.6

6300

116

368460.4

5064843.17

F30557

1.1

2005

126

368460.36

5064842.23

F30558

-5

0.5

1446

368460.28

5064841.33

F30559

0.8

1496

368460.26

5064840.34

F30560

-5

0.6

1087

368460.12

5064839.34

F30561

-5

0.4

1083

368460.04

5064838.37

F30562

-5

-0.2

122

220

368459.91

5064837.51

F30563

-5

0.4

807

91.5

368463.31

5064845.69

F30564

1.7

4320

147

368463.25

5064844.81

F30565

0.8

2690

368463.29

5064843.84

F30566

0.7

1447

368463.31

5064842.83

F30567

1923

368463.35

5064841.83

F30568

2.5

7340

368463.51

5064840.94

F30569

0.4

1032

368463.71

5064839.98

F30570

1880

368463.69

5064839.07

F30571

-5

0.3

453

368467.68

5064848.42

F30572

0.5

1312

368467.64

5064847.5

F30573

0.3

320

103

368467.45

5064846.58

F30574

0.9

1409

162

368467.27

5064845.6

F30575

104.5

1.85

7155

123

368467.06

5064844.78

F30576

0.6

1447

309

368466.53

5064844.04

TABLE 1 (CONTINUED):

Sample #

Au
PPB

Ag
PPM

Cu
PPM

Ni
PPM

Pb
PPM

Zn
PPM

UTM East
(N83Z18)

UTM North
(N83Z18)

F30577

0.9

1691

162

368466.42

5064843

F30578

1.1

1901

112

368466.4

5064842.1

F30579

2670

368466.35

5064841.1

F30580

1.7

2620

368466.32

5064840

F30581

2740

368466.22

5064839.06

F30582

0.9

2660

368466.13

5064838.12

F30583

0.5

1155

368469.93

5064848

F30584

-5

0.4

829

368469.86

5064846.98

F30585

494

7.6

22900

211

368469.78

5064846.11

F30586

1.2

2240

368469.61

5064845.17

F30587

0.65

1479

14.5

128.5

368469.44

5064844.19

F30588

195

3.2

7295

9.5

368469.28

5064843.27

F30589

1.9

4950

368469.18

5064842.31

F30590

-5

0.2

209

107

368469.07

5064841.31

F30591

-5

-0.2

151

168

368468.91

5064840.28

F30592

-5

-0.2

114

368468.85

5064839.42

F30593

-5

0.3

119

118

368468.78

5064838.74

F30594

0.7

1930

368473.99

5064850.23

F30595

-5

-0.2

301

368474.02

5064849.33

F30596

0.4

1070

368473.98

5064848.45

F30597

3110

213

368473.83

5064847.61

F30598

3130

303

368473.66

5064846.76

F30599

-5

0.4

760

234

368473.48

5064845.99

F30600

0.8

1551.5

8.5

12.5

123.5

368473.35

5064845.04

F30601

1.7

7270

368473.31

5064844.16

F30602

216

2.4

5330

368473.22

5064843.24

TABLE 1 (CONTINUED):

Sample #

Au
PPB

Ag
PPM

Cu
PPM

Ni
PPM

Pb
PPM

Zn
PPM

UTM East
(N83Z18)

UTM North
(N83Z18)

F30603

3.5

8500

368473.12

5064842.41

F30604

1.9

6180

309

368479.86

5064847.88

F30605

0.3

588

355

368479.74

5064846.96

F30606

0.5

1032

368479.56

5064845.98

F30607

0.6

1103

368479.41

5064845.02

F30608

2.1

5090

368479.3

5064843.95

F30609

1911

368479.15

5064842.95

F30610

-5

0.4

822

368479.01

5064842.01

F30611

-5

-0.2

237

100

368478.84

5064841.01

F30612

0.35

248.5

110.5

368478.73

5064840.02

F30613

-5

0.2

111

112

368478.6

5064839.08

F30614

0.2

131

157

368478.61

5064837.97

F30615

0.7

1657

143

368482.49

5064848.5

F30616

1.2

1982

368482.39

5064847.73

F30617

-5

0.3

451

368482.32

5064846.74

F30618

-5

0.3

891

368482.28

5064845.76

F30619

1.5

4970

368482.1

5064844.65

F30620

1.7

3990

368488.41

5064848.71

F30621

0.2

622

368488.45

5064847.83

F30622

-0.2

170

368488.46

5064846.88

F30623

0.2

325

368488.41

5064845.79

F30624

7.5

0.3

917.5

10.5

62.5

368488.39

5064844.85

F30625

1.95

6120

58.5

368481.92

5064843.52

F30626

1924

368481.72

5064842.56

F30627

-5

0.6

1566

122

368488.39

5064843.92

F30628

1.8

4430

368488.47

5064843.25

TABLE 1 (CONTINUED):

Sample #

Au
PPB

Ag
PPM

Cu
PPM

Ni
PPM

Pb
PPM

Zn
PPM

UTM East
(N83Z18)

UTM North
(N83Z18)

F30629

1.7

5760

368490.87

5064850.09

F30630

1.5

3560

113

368491.04

5064849.05

F30631

-5

0.5

1131

154

368491.26

5064848.1

F30632

-5

-0.2

211

368491.37

5064847.22

F30633

-5

-0.2

194

368491.61

5064846.25

F30634

-5

-0.2

624

368491.83

5064845.25

F30635

-5

0.4

968

368492.07

5064844.39

F30636

1.2

3160

368492.25

5064843.5

F30637

46.5

1.3

2690

9.5

368492.4

5064841.48

F30638

0.8

1924

368492.34

5064842.51

F30639

-5

0.3

749

368481.3

5064841.5

F30640

-5

-0.2

158

124

368481.24

5064840.56

F30641

-5

-0.2

108

192

368481.24

5064839.66

F30642

-5

-0.2

480

368494.07

5064852

F30643

-5

-0.2

414

368494.24

5064851.03

F30644

0.6

1467

368494.4

5064850.08

F30645

1.5

3840

368494.48

5064849.11

F30646

1.3

2790

368494.7

5064848.18

F30647

-5

-0.2

221

368494.92

5064847.21

F30648

-5

0.2

460

368495.06

5064846.37

F30649

-5

-0.2

194

10.5

88.5

368495.16

5064845.31

F30650

-5

-0.2

307

368495.27

5064844.61

F30651

1.3

2530

368495.67

5064842.97

F30652

0.6

1250

234

368496.08

5064841.95

F30653

2.3

8690

154

368496.36

5064841.08

F30654

-0.2

584

368498.05

5064852.31

TABLE 1 (CONTINUED):

Sample #

Au
PPB

Ag
PPM

Cu
PPM

Ni
PPM

Pb
PPM

Zn
PPM

UTM East
(N83Z18)

UTM North
(N83Z18)

F30655

0.2

1024

368498.06

5064851.41

F30656

0.3

1619

368498.08

5064850.38

F30657

-5

0.3

755

368498.15

5064849.37

F30658

2.1

5160

368498.22

5064848.31

F30659

-5

0.4

557

198

368498.23

5064847.35

F30660

0.3

653

368498.34

5064846.33

F30661

-5

0.35

901

10.5

67.5

368498.77

5064845.35

F30665

-5

0.3

1312

104

368508.5

5064843.84

F30666

1.8

4100

368508.2

5064842.6

F30667

1.2

2840

184

368511.42

5064843.93

F30668

1.5

3150

368511.33

5064843

F30669

-5

0.4

726

368511.16

5064841.99

F30670

-5

-0.2

527

322

368514.56

5064845.41

F30671

644

5730

160

368514.5

5064844.5

F30672

1.4

2880

368514.33

5064843.46

F30673

-0.2

709

368519.1

5064848.01

F30674

40.5

1.35

5010

10.5

96.5

368518.78

5064847.07

F30675

1.3

3230

368518.39

5064845.99

F30676

0.5

1095

368518.17

5064844.99

F30677

0.8

1546

213

368517.94

5064844.02

F30678

108

2.6

5900

278

368517.76

5064843.16

F30679

190

2.8

9070

368517.57

5064842.13

F30680

1.8

6290

368517.2

5064841.25

F30681

-5

0.2

890

368517.05

5064840.3

F30682

1.8

6160

368516.99

5064839.29

F30683

-5

-0.2

597

368516.9

5064838.04

TABLE 1 (CONTINUED):

Sample #

Au
PPB

Ag
PPM

Cu
PPM

Ni
PPM

Pb
PPM

Zn
PPM

UTM East
(N83Z18)

UTM North
(N83Z18)

F30684

1.2

4210

127

368522.3

5064848.95

F30685

0.6

1079

368522.38

5064848.12

F30686

-5

0.7

1794

15.5

93.5

368522.46

5064847.12

F30687

-5

0.8

1492

427

368522.48

5064846.14

F30688

-5

0.4

763

572

368522.45

5064845.34

F30689

-5

0.4

1397

368522.46

5064844.74

F30690

162

2.3

7010

368522.35

5064844.04

F30691

1.6

3700

368522.24

5064843.18

F30692

-5

0.6

1257

116

368522.21

5064842.18

F30693

-5

0.2

814

368522.26

5064841.43

F30694

-5

-0.2

197

368522.17

5064840.74

F30695

-5

-0.2

713

134

368522.08

5064839.78

F30696

0.6

1450

122

368525.67

5064847.03

F30697

0.4

1199

126

368525.61

5064846.04

F30698

0.5

1494

108.5

368525.59

5064845.06

F30699

2.15

6425

15.5

299

368525.51

5064844.09

F30700

178

2.6

5840

148

368525.36

5064843.12

F30701

2.5

3610

368525.3

5064842.16

F30702

0.9

1789

200

368525.36

5064841.1

F30703

-5

0.8

1598

116

368525.47

5064840.09

F30704

2.3

6400

130

368528.15

5064848.41

F30705

2.2

4170

113

368527.88

5064847.49

F30706

0.3

448

368527.66

5064846.55

F30707

-5

0.2

268

368527.56

5064845.51

F30708

-5

0.4

548

368527.52

5064844.58

F30709

1.2

4160

368527.49

5064843.67

TABLE 1 (CONTINUED):

Sample #

Au
PPB

Ag
PPM

Cu
PPM

Ni
PPM

Pb
PPM

Zn
PPM

UTM East
(N83Z18)

UTM North
(N83Z18)

F30710

1860

368527.32

5064842.68

F30711

0.35

488

2.5

368527.4

5064841.72

F30712

0.5

1020

149

368527.38

5064840.79

F30713

-5

0.4

718

139

368527.41

5064840.1

F30714

-5

0.3

856

108

368531.51

5064848.09

F30715

2.6

5880

747

368531.48

5064847.12

F30716

-5

0.7

1085

204

368531.41

5064846.03

F30717

-5

0.5

1164

101

368531.34

5064845.14

F30718

0.8

1751

148

368531.29

5064844.11

F30719

-5

0.6

774

368531.15

5064843.21

F30720

0.3

487

368531

5064842.15

F30721

1.4

4330

113

368533.69

5064847.82

F30722

1.5

4410

130

368533.7

5064846.86

F30723

0.4

479.5

-2

11.5

368533.8

5064846

F30724

1.3

2670

368533.62

5064845.12

F30726

1.1

1503

368533.52

5064844.07

F30727

148

3.3

12600

160

368533.43

5064843.13

F30728

118

1.8

8050

119

368533.09

5064841.98

F30736

17.5

0.65

1629

12.5

368496.59

5064840.08

F30737

1.9

5630

368496.68

5064839.08

F30738

0.7

1617

368496.73

5064838.09

F30739

0.6

1266

368496.65

5064837.31

F30740

0.3

290

368496.6

5064836.61

F30741

-5

0.2

383

368496.55

5064835.84

F30742

0.3

1358

368496.54

5064835.26

F30743

-0.2

293

368496.32

5064834.49

TABLE 1 (CONTINUED):

Sample #

Au
PPB

Ag
PPM

Cu
PPM

Ni
PPM

Pb
PPM

Zn
PPM

UTM East
(N83Z18)

UTM North
(N83Z18)

F30744

-5

0.4

925

368506.65

5064843.2

F30745

-5

0.6

1304

368506.56

5064842.04

F30746

1.9

5420

368506.68

5064840.98

F30747

0.4

1202

368506.76

5064839.86

F30748

-0.2

826.5

51.5

368506.92

5064838.6

F30749

0.5

1105

368507.1

5064837.28

F30755

0.7

1651

368508.38

5064841.39

F30756

-5

0.3

1055

104

368508.61

5064840.2

F30757

-0.2

687

368508.72

5064839.14

F30758

-5

-0.2

582

368508.7

5064838.24

F30759

0.6

1507

368511.27

5064840.94

F30760

-5

-0.2

676

368511.09

5064839.97

F30761

-5

-0.2

501

368511.01

5064839.03

F30762

-5

-0.2

430

12.5

66.5

368510.91

5064837.95

F30763

1.9

6270

368514.09

5064842.62

F30764

-5

-0.2

985

368513.99

5064841.64

F30765

-5

-0.2

525

368513.88

5064840.83

F30766

-5

-0.2

370

368513.7

5064839.92

F30767

0.7

3020

368513.59

5064838.99

F30768

-5

-0.2

280

368513.62

5064837.99

F30770

-5

-0.2

262

368513.52

5064836.98

SOURCE: Sphinx Resources Ltd.

ReleaseID: 578265

Deadline Reminder: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Westpac Banking Corporation

BENSALEM, PA / ACCESSWIRE / February 27, 2020 / Law Offices of Howard G. Smith reminds investors of the upcoming March 30, 2020 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who acquired Westpac Banking Corporation ("Westpac" or the "Company") (NYSE:WBK) securities between November 11, 2015 and November 19, 2019, inclusive (the "Class Period").

Investors suffering losses on their Westpac investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in this class action at 888-638-4847 or by email to howardsmith@howardsmithlaw.com.

On November 19, 2019, Westpac was charged by the Australian Transaction Reports and Analysis Centre ("AUSTRAC") with over 23 million violations of the Anti-Money Laundering and Counter-Terrorism Financing Act (the "AML-CTF Act"). Among other things, AUSTRAC's Statement of Claim contends that the Company failed to distinguish money laundering or risky payments to and from Southeast Asia indicative of child sexual exploitation, despite Westpac senior management being "specifically briefed" in 2016 on how the bank's international digital payments service could be at risk for such abuse.

On this news, the Company's share price fell $0.80, or over 4%, to close at $17.15 per share on November 20, 2019, thereby injuring investors.

The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company's business, operations, and prospects. Specifically, Defendants failed to disclose to investors: (1) that contrary to Australian law, the Company failed to report over 19.5 million international funds transfer instructions to AUSTRAC; (2) that the Company did not appropriately monitor and assess the ongoing money laundering and terrorism financing risks associated with movement of money into and out of Australia; (3) that the Company did not pass on requisite information about the source of funds to other banks in the transfer chain; (4) that despite being aware of the heightened risks, the Company did not carry out appropriate due diligence on transactions in South East Asia and the Philippines that had known financial indicators relating to child exploitation risks; (5) that the Company's AML/CTF Program was inadequate to identify, mitigate and manage money laundering and terrorism financing risks; and (6) that as a result, Defendants' statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

If you purchased Westpac securities during the Class Period, you may move the Court no later than March 30, 2020 to ask the Court to appoint you as lead plaintiff if you meet certain legal requirements. To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action. If you wish to learn more about this class action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, toll-free at (888) 638-4847, or by email to howardsmith@howardsmithlaw.com, or visit our website at www.howardsmithlaw.com.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Law Offices of Howard G. Smith
Howard G. Smith, Esquire
215-638-4847
888-638-4847
howardsmith@howardsmithlaw.com
www.howardsmithlaw.com

SOURCE: Law Offices of Howard G. Smith

ReleaseID: 578077

Deadline Reminder: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Six Flags Entertainment Corporation (SIX)

BENSALEM, PA / ACCESSWIRE / February 27, 2020 / Law Offices of Howard G. Smith reminds investors of the upcoming April 13, 2020 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who acquired of Six Flags Entertainment Corporation ("Six Flags" or the "Company") (NYSE:SIX) securities between April 25, 2018 and January 9, 2020 inclusive (the "Class Period").

Investors suffering losses on their Six Flags investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in this class action at 888-638-4847 or by email to howardsmith@howardsmithlaw.com.

In June 2014, Six Flags announced an exclusive agreement with Riverside Investment Group Co. Ltd. ("Riverside"), which would provide capital investment for future developments in China.

On February 14, 2019, Six Flags disclosed a $15 million revenue adjustment for fourth quarter 2018 due to delays in expected opening dates of some parks in China. In the press release, the Company stated that "[t]his resulted in a 38 percent decline in sponsorship, international agreements and accommodations revenue compared to the fourth quarter of 2017."

On this news, the Company's share price fell $9.00, or over 14%, to close at $54.87 per share on February 14, 2019, on unusually heavy trading volume.

Then, on October 23, 2019, Six Flags postponed park openings in China and stated that "it's unrealistic to think it's going to be exactly as we've outlined."

On this news, the Company's share price fell $6.35, or over 12%, to close at $44.88 per share on October 23, 2019, on unusually heavy trading volume.

Then, on January 10, 2020, Six Flags announced that parks in China continued to encounter challenges and that the Company expected a $1 million revenue adjustment related to certain agreements.

On this news, the Company's share price fell $7.80, or nearly 18%, to close at $35.96 per share on January 10, 2020, on unusually heavy trading volume.

The complaint alleges that defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) Riverside faced far more financial distress than disclosed to investors; (2) as a result, there was a high likelihood that Riverside would default on its payment obligations to the Company; (3) the Company's international strategy, which relied predominantly on its exclusive agreements with Riverside to develop Six Flags-branded parks in China to drive revenue growth, was significantly less promising than represented to investors; and (4) as a result of the foregoing, Defendants' statements about the Company's business, operations and prospects lacked a reasonable basis.

If you purchased Six Flags securities during the Class Period, you may move the Court no later than April 13, 2020 to ask the Court to appoint you as lead plaintiff if you meet certain legal requirements. To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action. If you wish to learn more about this class action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, toll-free at (888) 638-4847, or by email to howardsmith@howardsmithlaw.com, or visit our website at www.howardsmithlaw.com.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Law Offices of Howard G. Smith
Howard G. Smith, Esquire
215-638-4847
888-638-4847
howardsmith@howardsmithlaw.com
www.howardsmithlaw.com

SOURCE: Law Offices of Howard G. Smith

ReleaseID: 578076